This document discusses inflammatory arthritis and its effects on the chest and lungs as seen on HRCT imaging. It covers various patterns of interstitial lung disease that can be seen, such as NSIP, UIP, OP, and LIP, and their associations with specific rheumatologic conditions like RA, SSc, and SLE. It provides imaging findings and characteristics of different ILD patterns. It emphasizes the importance of screening and surveillance of pulmonary involvement in rheumatologic diseases.
2. PURVIEW
• Chest findings - challenge in both diagnosis and management
• Contribute to significant morbidity and mortality
• Manifestation or a presenting feature of the collagen vascular
disease
• Practical approach
• History, physical examination, radiological, laboratory &
histopathological
• Screening and Surveillance
• Demographic, Serological, Biomarkers
• Established and emerging treatment
4. COLLAGEN VS. DISEASE – COMMONLY AFFECTED IN
ILD
• Rheumatoid arthritis – RA – Associated with NSIP
• Progressive systemic sclerosis – SSc / Scleroderma
• Dermatomyositis / Auto immune myositis- AIM – Associated with DAD
• Systemic lupus erythematosus – SLE – Associated with Diffuse alveolar
damage
• Sjogrens syndrome – associated with LIP
• Undifferentiated rheumatoid disorders
• Rheumatic related UIP similar mortality as IPF (Idiopathic pulmonary
fibrosis)
• Histological pattern may overlap AIM – overlap of NSIP and OP
5. HRCT
• Narrow slice thickness
(1mm) at 10mm interval
• High spatial resolution
image reconstruction
• End inspiratory view
• Window width of 1300
with Window Level of -
600 HU
• Mediastinal window
width 45, level of 420
width.
6. HRCT CHEST – “INFLAMMATORY ARTHRITIS”
• Advancements in imaging technology have improved our ability to
diagnose what once was thought to be a relatively rare complication is
now suspected to affect 20–30% of RA patients
• Commonest with SSc, RA, SLE and least common in Sjogren’s
• Males predominate with RA 43.7% while female predominance in SLE
41.4%
• Interstitial pattern (40%), Pleural fibrosis (28%) Consolidation (18.7%)
• DAD superimposed on underlying pulmonary fibrosis
• Smokers – Desquamative / respiratory bronchiolitis
7. HRCT FINDINGS IN ILD
• Reticular – Thickened inter and intra lobular septae
• Infiltration – fibrosis, abnormal cells or fluid
• Interlobular septal thickening – smooth or irregular
• Fine reticular pattern
• Honey combing
• late stage cystic air space surrounded by irregular walls
RadioGraphics 2012;32:33–50 •Published online10.1148/rg.321105058
8. RETICULAR – THICKENED INTER AND INTRALOBULAR
SEPTA
• Fine, Coarse thickening
- Width
• Fluid, Fibrous, Infiltrates
• Many conditions
• Pulmonary edema
• Lymphanngitis carcin’
• Alveolar proteinosos
• IPF
• Drug related disease
• Amylodois
• Collagen vascular dis’
12. • Fine thickening
of the inter and
intra-lobular
septae
• With or without
GGO
• Pulmonary
edema
• Sarcoidosis
FINE RETICULAR PATTERN
13. HONEY COMBING – LATE STAGE
CYSTIC AIR SPACE SURROUNDED BY IRREGULAR
WALLS
• Image
14. NON SPECIFIC INTERSTITIAL PNEUMONIA – NSIP
• Chronic progressive ILD commonly seen
especially in AIM & SSc
• Better prognosis
• Fibrotic NSIP May prognosctically
parallel UIP
• Radiological diagnosis may need to be
histo-pathologically confirmed
• Cellular NSIP – Ground Glass Density No
honeycombing / tractional
bronchiectasis / Infection
• Empirical anti-inflammatory therapy
15. CRAZY PAVING PATTERN
• Acute exacerbation of chronic
progressive ILD
• GGO with / out inter and
intralobular septal thickening
• Diffuse alveolar damage
• Fibrotic changes – bronchiectasis,
reticulation, honeycombing
• D/D – opportunistic infection
– drug induced disease
• Smoking – Desquamative /
bronchiolitis
16. USUAL INTERSTITIAL PNEUMONIA - UIP
• Commonly seen especially in RA
• Poor prognosis – 5 year mortality of >50%
• Present in upto 60% cases of RA associated
ILD – RA-ILD
• Disease modifying anti rheumatic drugs -
DMARD
• Mycophenolate mofetil – MMF
• Azathioprine – AZA
• PANTHER-IPF Trial – evaluates anti-
inflammatory therapy with deleterious results
in UIP related to IPF raises similar concerns
with UIP related to RA
• Prospective trials with anti-fibrotic agents
• Referral for transplant
17. ORGANIZING PNEUMONIA - BOOP
• Commonly seen especially in AIM
particularly in anti-synthetase
syndrome
• Intraluminal fibrosis in distal airway
with associated interstitial
inflammation
• Radiologically – consolidation, nodules
• Unique features – atoll sign / reverse halo
sign
• Central GGO with surrounding denser air
space consolidation in an crescentic / ring
shape
• Worse prognosis in OP related to RA
as compared to cryptogenic OP
18. ORGANIZING PNEUMONIA - OP
OP in a previously well
individual with or without
new systemic complaints
will merit a detailed
investigation for
underlying autoimmune
disorder – especially anti-
synthetase syndrome
19. ANTI-SYNTHETASE SYNDROME
• Historical / Physical
• very high rates of ILD
• Grotton’s nodules – extensor
surface
• Common Imaging findings
• Pneumo mediastinum has been
noted in this population, as well
as in patients with
dermatomyositis without MDA5
(melanoma diff associated pr 5)
• Limited responsie & necessitates
early aggressive therapy -
Transplanation
• Typical serological attributes
• presence of antibodies to
20. LYMPHOCYTIC INTERSTITIAL PNEUMONIA - LIP
• Commonly seen in Sjogrens
syndrome
• may complicate RA & SSc
• Lympho-plamacytic infiltrates
• nodules and lymphoid follicles
• Nodules may appear inflammatory in
LIP but more likely Lymphoma
• MALT – mucosa associated lymphoid
tissue
• RA and Sjogrens syndrome are prone
to develop Lymphoma
• Biopsy is warranted
21. PULMONARY MANIFESTATIONS IN RHEUMATOID A.
• Follicular bronchiolitis
• Constrictive bronchiolitis
• Obstructive bronchiolitis
• Bronchiectasis
• Emphysema
• Coexist with ILD especially in RA
• Airway changes in RA especially
upper airway in exposure to antigens
(citrulline) & autoimmune response
may initiate or propagate RA
• ACPA – Anti citrulillinated protein antibody
22. PULMONARY MANIFESTATIONS IN RA
• Bronchiectasis is common with RA
• Increase risk of secondary infection
especially when RA is treated with
biological agents
• Follicular bronchiolitis – Obstruction
on PFT with declining respiratory
status
• Air trapping / Mosaicism on HRCT
raise possibility of reversible and
treatable disease and less likely
obliterative bronchiolitis
(not responsive unless the offending
drug is identified and removed)
• Concomitant emphysema – previous
smoking history
23. PULMONARY NODULES
• D/D – opportunistic infection
• Nocardia, Cryptocous, Aperrgillus, AMTB
• Neoplasm – Carcinoma /
Lymphoma
• Metabolic – Amyloidosis
• Immunological – Rheumatoid
Nodule
• Cavitate – 50%
• Often asymptomatic may often rupture
• Pneumothorax, hemoptysis & infection
• Inflammatory nodules in RA & Sjogrens
syndrome May mimic malignancy –
Mandate biopsy
• “Caplans Syndrome” with Pneumoconiosis
24. PLEURAL INFLAMMATION AND EFFUSION
• Commonly seen in
RA, SLE and
occasionally Systemis
sclerosis & Sjogrens
syndrome
• Exudative effusions
with low glucose and
pH value in RA
• “Shrinking lung”
syndrome in SLE is
likely due to
persistent pleural
inflammation
25. SSC – SYSTEMITC SCLEROSIS / SCLERODERMA
• Common Imaging findings
• > 50 % patients with earlier
development
• NSIP / UIP /OP /AIP/DAD /DAH
• Common in diffuse SSc – where the
elbows and knees are involved
• Typical serological attributes
• ANA
• Special
• Nucleolar pattern, anti centromere
pattern
• Early diagnosis and treatment
• Older male patients, antibody positive
African American
• Early decline in FVC
26. AIM (AUTO IMMUNE MYOSITIS) / IDIOPATHIC MYOPATHY
• Historical / Physical
• Idiopathic inflammatory
• Dysphagia, proximal muscle weakness,
photosensitive, Pulmonary arterial H’Tn
• Common Imaging findings
• Respiratory muscle dysfunction, aspiration
• NSIP & OP followed by UIP and AIP
• AIP/DAD Pneumo-mediastinum
• Poor prognosis in older age groups
• Concomitant PAH is prognostic indicator
• Typical serological attributes
• Creatinine kinase, aldolase
• Special
• Skin nodules, dermatomyositis, and ILD
• PAH
• Commonest in
• SSc
• Mixed conncective tissue disease
• Less common
• SLE
• RA - Rare
30. MIXED CONNECTIVE TISSUE DISEASE
• Historical / Physical
• Variable signs &
symptoms primarily
associated with SLE, SSc,
and AIM
• Common Imaging
findings
• NSIP
• LIP
• Typical serological attributes
• ANA
• Special
• Nuclear speckled pattern
31. HRCT PREDICTORS OF PROGRESSIVE FA IN CVD
• FA – Fibrosing alveolitis
• Progression > 15 % TLCO
• Increased GGO
• Increased reticular pattern
• Bi-basal crackles
• Exudative / Reparative
phase
• carbon monoxide transfer
factor (TLCO)
32. SSC – HRCT SCORING FOR EVALUATING ILD
• HRCT gold standard for SSc – ILD
• 20 Yrs. Previously used to assess IPF
• Wells et. al. Parenchymal and reticular
• Morelli et. al. 3 zones
• Apices to carina
• Carina to inferior pulmonary veinous confluence
• Pulmonary vein to diaphragm
• Parenchymal opacification 1
• Parenchymal opacification > reticular pattern extent 2
• Parenchymal opacification = reticular pattern extent 3 Anatomical region scored
• Reticular pattern > parenchymal opacification 4
• Reticular patter alone 5
33. SCREENING FOR ILD – INFLAMMATORY
ARTHRITIS
• Early referral
• Symptoms (dyspnea, cough)
• Physical examination findings (ambulatory hypoxemia)
• Clubbing, Bibasilar crackles
• Decrements on baseline PFTs
• restrictive lung disease or diminished 6-min walk distance
• ILD seen on HRCT
• ILD with associated Arthritis
• Cross referral to rheumatologist on suspicion
34. RAPIDLY PROGRESSIVE ILD - HOSPITALIZED
PATIENT
• Unexplained progression / rapidly progressive respiratory disease
• SSc Spectrum
• Sclerodactaly
• Limited oral aperture
• Nail fold capillary changes
• Telangectsia
• Adult onset reynaud’s
• Dermatomyositis or anti-synthetase syndrome (both)
• Skin rashes on extremities or face (both)
• Nodules, diffuse erythema, plaques on the extensor surfaces
• Periungual erythema, nail fold capillary microscopic changes
• “mechanics hands,” which are fissures and cracking seen on the tips and radial aspect of
the fingers
35. RAPIDLY PROGRESSIVE ILD - HOSPITALIZED
PATIENT
• RA
• Symmetrical inflammatory arthritis in the hands and feet
• SLE
• skin rash, livedo reticularis, and joint pain,
• young female patients
• Vasculitis ANCA – (Antineutrophil cytoplasmic antibody)
associated disease
• sinusitis with or without epistaxis, otitis, nasal septal
perforation
• palpable purpura, and mononeuritis multiplex
36. SPECIFIC SEROLOGICAL TEST – HRCT IN UNCLEAR PHENOTYPE
• Definite UIP
• Rheumatoid Factor, CCP – anti cyclic citrullinated peptide, ANA, ANCA
• NSIP, OP, Undefined or AIP
• Anti nuclear antibody – ANA, RF, anti CCP, myositis anti body panel
• creatinine kinase, aldolase, Melanoma differentiatin associated protein MDA5
• Bronchiolitis (obliterative bronchiolitis)
• RF, anti-CCP
• Diffuse alveolar hemorrhage
• ANCA, ANA, antiphospholipid antibody, cryo globulins, anti glomerular basement
membrane antibody
• LIP
ANA, RF, anti-CCP
37. ILD IN ARTHRITIS APPROACH TO SCREENING
• Consensus based
• Early referral to pulmonary medicine
• Dyspnea / cough
• Physical examination
• Ambulatory hypoxemia, clubbing, bibasilar crackles
• Decrimental baseline PFT
• Restrictive lung disease, diminished 6 minute walking distance
• ILD seen on HRCT
• Warrants detailed rheumatological evaluation
38. SYSTEMIC SCLEROSIS
• Early evidence of ILD and PAH is standard care
• Screening baseline PFT – Spirometery, TLC, Diffusion Capacity
• Echocardiography
• HRCT
• Normal is encouraging, abnormal baseline scan variable progression
• Follow up with > 20% fibrotic lung
• Follow up annual PFT
• >10 % FVC or > 15 % DLCO
• 6 minute walking test
not validated in SSc can be useful in follow up evaluation.
• Oesophageal dysmotility and aspiration risk.
39. AIM – AUTOIMMUNE MYOSITIS
• Anti-synthetase syndrome
• Screening
• HRCT and PFT
• HRCT abnormal and patient is symptomatic with < 70 % FVC
treated
• PFT biannually at 3 to 6 months
• Oesophageal dysmotility.
• PAH
40. RHEUMATOID ARTHRITIS
• HRCT in high risk – older male smoker
• PFT 3 to 6 months if the HRCT is abnormal
• Decline of 10 % in PFT in an RA – ILD higher mortality
risk
• CT scanning for cancer screening
• Subclinical ILD
41. PRESENT AND FUTURE
• Predominantly anti inflammatory
• Emerging agents targeting fibrosis
• Cellular NSIP & OP
• Cyclophosphamide, AZA, Calcineurin inhibitor
• Fibrosing NSIP or UIP
• Pirfenidone, Nintedanib
• ILD with Lymphoid LIP in RA or Sjogrens syndrome
• B Cell deletion – Rituximab
42. IN SUMMARY
20
11
3
7
5
29
75
0 10 20 30 40 50 60 70 80
RA
SLE
Sjogren's
SSc
Polymyositis
Scleroderma
Total
Total Bronchiectasis Lymphadenopathy
44. IN SUMMARY
Intersection between pulmonary and rheumatologic disease represents
a unique and often ambiguous paradigm of medicine requires
vigilance and meticulous assessment but most importantly a
multidisciplinary approach involving
• Pulmonary medicine
• Rheumatology
• Radiology
• Pathology
• Thoracic surgery and other disciplines.
Greater recognition and understanding of these disorders, Improved
diagnostic and screening strategies, and more targeted therapies
Outcomes and quality of life for this group of challenging patients will
45. THANK YOU FOR YOUR KIND
ATTENTION
Facebook – Medical Imaging Portal
Editor's Notes
Systemic sclerosis – SSc / Scleroderma Commonest upto 38%
Auto immune myositis- AIM
Rheumatoid arthritis – RA upto 60% RA-ILD
Systemic lupus erythematosus – SLE 14.6% o
Sjogrens syndrome least common with 4%
air-containing cystic spaces having thick, fibrous walls lined by bronchiolar epithelium
Typical
Ground-glass opacities, mild reticulation,traction bronchiectasis and bronchiolec-tasis, absent honeycombing in the earlystages
Typical Distribution
Ground-glass opacities, mild reticulation,traction bronchiectasis and bronchiolec-tasis, absent honeycombing in the earlystages
Unusual Finding
Extensive reticular pattern, consolida-tion (may represent areas of co-exist-ing organizing pneumonia – BOOP),peribronchovascular distribution
Diffuse Alveolar Damage
Typical findings
Ground-glass opacity, “crazy paving” pattern, bilateral areas of consolidation maybe present mainly in dependent regions
Typical distribution
Bilateral and diffuse, rarely multifocal
Unusual finding
May progress to pulmonary fibrosis. Patients who survive may have HRCT pattern similar to non-specific interstitial pneumonia
Typical findings
Reticular pattern, bronchiectasis andtraction bronchiectasis, honeycombing,absent or minimal ground-glass opacities
Typical distribution
Peripheral, basal and posterior pre-dominance
Unusual finding
Asymmetrical distribution, major in-volvement of upper lobes
Typical finding
Consolidation is the typical finding,ground-glass opacity usually is associatedwith areas of consolidation, perilobularpattern or reversed halo sign may befound
Typical distribution
Bilateral symmetrical or asymmetrical,peripheral and/or peribronchovascularin 60–80% of cases, predominance inlower lobes
Unusual finding
Focal consolidation mimicking massmay progress to fibrosis
Cryptogenic organizing pneumonia in a 69-year-old woman with polymyositis. Axial high-resolution CT image of the left lung shows consolidation in the lower lobe with multiple occurrences of the reverse halo sign (arrows), a feature characterized by a ring-shaped opacity surrounding a region of ground-glass opacity.
MDA5 - Autoantibodies against melanoma differentiation-associated protein 5
Typical finding
Ground-glass opacities associated withsparse cysts ranging from 1–3 cm in di-ameter
Typical distribution
May be diffuse or predominate in thelower lobes; cysts may have subpleu-ral and peripheral distribution
Unusual finding
Isolated pulmonary cysts, ground-glassopacity as an isolated finding, septalthickening, and centrolobular nodules
CAPLANS SYNDROME
Shrinking lung syndrome, defined as a progressive loss of lung volume with associated dyspnea and pleuritic chest pain, was first described in 1965 (53).This is an uncommon manifestation of systemic lupus erythematosus, with a prevalence of only 0.6%
systemic disorder characterized by excessive fibroblast proliferation, autoimmunity, and endothelial dysfunction leading to organ dysfunction involving the skin, lung, heart, and kidneys.
Pulmonary involvement in ankylosing spondylitis in a 44-year-old man. Coronal high-resolution CT image shows apical reticular opacities with fibrosis, and a cavity containing an aspergilloma in the left lung.
Pulmonary hypertension in a 27-year-old woman with progressive systemic sclerosis. Unenhanced axial CT image depicts enlargement of the pulmonary artery(PA)trunk and a substantial amount of pericardial effusion (arrows) in the anterior superior aortic recess.
Historical / Physical
Idiopathic inflammatory
Dysphagia, proximal muscle weakness, photosensitive rash on hands/chest/face/back ,mechanics hands, anti synthetase syndrome (Raynaud syndrome, mechanics hands, fever, arthritis, ILD)
Common Imaging findings
morbidity and mortality relates to associated lung disease, including respiratory muscle dysfunction, aspiration, and ILD, most notably NSIP and OP followed by UIP and AIP
NSIPOPUIPAIP/DAD Pneumo mediastinum
Poor prognosis in worse prognosis is noted in older age groups, acute and subacute presentations with low initial FVC, amyopathic cases, and when concomitant PAH is present
Typical serological attributes
Creatinine kinase, aldolase
Special
Skin nodules, dermatomyositis, and ILD
Historical / Physical
Idiopathic inflammatory
Dysphagia, proximal muscle weakness, photosensitive rash on hands/chest/face/back ,mechanics hands, antisynthetase syndrome (Raynaud syndrome, mechanics hands, fever, arthritis, ILD)
Common Imaging findings
morbidity and mortality relates to associated lung disease, including respiratory muscle dysfunction, aspiration, and ILD, most notably NSIP and OP followed by UIP and AIP
NSIPOPUIPAIP/DAD Pneumomediastinum
Poor prognosis in worse prognosis is noted in older age groups, acute and subacute presentations with low initial FVC, amyopathic cases, and when concomitant PAH is present
Typical serological attributes
Creatinine kinase, aldolase
Special
Skin nodules, dermatomyositis, and ILD
Diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. Axial high-resolution CT image obtained in a 34-year-old woman with dyspnea, hemoptysis, and a low serum hemoglobin level shows bilateral central ground-glass opacities. The combined clinical and imaging findings are indicative of diffuse alveolar hemorrhage.
NSIP in a 52-year-old womanwith mixed connective tissue disease. Axialhigh-resolution CT image demonstrates re-ticular abnormalities and peripheral ground-glass opacities in the lower lung lobes (ar-rows) with relative subpleural sparing.
carbon monoxide transfer factor (TLCO)
Predictors of progression of HRCTdiagnosed fibrosing alveolitis inpatients with rheumatoid arthritis
J K Dawson1,H E Fewins2,J Desmond3,M P Lynch1,D R Graham4
BMJ Volume61,Issue6
systemic disorder characterized by excessivefibroblast proliferation, autoimmunity, and endothelialdysfunction leading to organ dysfunction involving theskin, lung, heart, and kidneys.
systemic disorder characterized by excessive fibroblast proliferation, autoimmunity, and endothelial dysfunction leading to organ dysfunction involving the skin, lung, heart, and kidneys.